Annual Current Assets
$156.19 M
+$21.90 M+16.31%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual total current assets is $156.19 million, with the most recent change of +$21.90 million (+16.31%) on December 31, 2023.
- During the last 3 years, PBYI annual current assets has risen by +$10.05 million (+6.87%).
- PBYI annual current assets is now -33.95% below its all-time high of $236.47 million, reached on December 31, 2016.
Performance
PBYI Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$156.82 M
+$19.10 M+13.87%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly total current assets is $156.82 million, with the most recent change of +$19.10 million (+13.87%) on September 30, 2024.
- Over the past year, PBYI quarterly current assets has increased by +$31.46 million (+25.10%).
- PBYI quarterly current assets is now -50.48% below its all-time high of $316.69 million, reached on March 31, 2015.
Performance
PBYI Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
PBYI Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.3% | +25.1% |
| 3 y3 years | +6.9% | +37.2% |
| 5 y5 years | -23.1% | +37.2% |
PBYI Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.3% | at high | +40.3% |
| 5 y | 5-year | -6.1% | +16.3% | -6.5% | +40.3% |
| alltime | all time | -34.0% | >+9999.0% | -50.5% | -100.0% |
Puma Biotechnology Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $156.82 M(+13.9%) |
| Jun 2024 | - | $137.72 M(-3.7%) |
| Mar 2024 | - | $143.03 M(-8.4%) |
| Dec 2023 | $74.34 M(-15.3%) | $156.19 M(+24.6%) |
| Sep 2023 | - | $125.35 M(+5.7%) |
| Jun 2023 | - | $118.55 M(+6.1%) |
| Mar 2023 | - | $111.75 M(-16.8%) |
| Dec 2022 | $87.78 M(+1.4%) | $134.28 M(+9.7%) |
| Sep 2022 | - | $122.35 M(+7.1%) |
| Jun 2022 | - | $114.28 M(-2.8%) |
| Mar 2022 | - | $117.57 M(-16.0%) |
| Dec 2021 | $86.56 M(-11.7%) | $140.02 M(+2.3%) |
| Sep 2021 | - | $136.92 M(-18.4%) |
| Jun 2021 | - | $167.75 M(+2.4%) |
| Mar 2021 | - | $163.76 M(+12.1%) |
| Dec 2020 | $98.08 M(+43.0%) | $146.14 M(-8.6%) |
| Sep 2020 | - | $159.80 M(+0.4%) |
| Jun 2020 | - | $159.22 M(+0.3%) |
| Mar 2020 | - | $158.68 M(-4.6%) |
| Dec 2019 | $68.61 M(+22.3%) | $166.30 M(+10.1%) |
| Sep 2019 | - | $151.09 M(-4.1%) |
| Jun 2019 | - | $157.61 M(-38.5%) |
| Mar 2019 | - | $256.16 M(+26.2%) |
| Dec 2018 | $56.12 M(-5.1%) | $203.00 M(+16.4%) |
| Sep 2018 | - | $174.41 M(+2.6%) |
| Jun 2018 | - | $170.06 M(+53.0%) |
| Mar 2018 | - | $111.19 M(+4.5%) |
| Dec 2017 | $59.13 M(+262.4%) | $106.39 M(-11.0%) |
| Sep 2017 | - | $119.60 M(-25.6%) |
| Jun 2017 | - | $160.80 M(-21.4%) |
| Mar 2017 | - | $204.63 M(-13.5%) |
| Dec 2016 | $16.32 M | $236.47 M(+101.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $117.40 M(-23.6%) |
| Jun 2016 | - | $153.75 M(-18.8%) |
| Mar 2016 | - | $189.36 M(-15.3%) |
| Dec 2015 | $16.29 M(+21.8%) | $223.55 M(-12.2%) |
| Sep 2015 | - | $254.66 M(-11.5%) |
| Jun 2015 | - | $287.78 M(-9.1%) |
| Mar 2015 | - | $316.69 M(+112.0%) |
| Dec 2014 | $13.38 M(+67.7%) | $149.38 M(-6.7%) |
| Sep 2014 | - | $160.10 M(-12.8%) |
| Jun 2014 | - | $183.60 M(-13.3%) |
| Mar 2014 | - | $211.66 M(+119.6%) |
| Dec 2013 | $7.98 M(+192.6%) | $96.40 M(-12.8%) |
| Sep 2013 | - | $110.58 M(-10.4%) |
| Jun 2013 | - | $123.44 M(-10.7%) |
| Mar 2013 | - | $138.20 M(-7.2%) |
| Dec 2012 | $2.73 M(+57.2%) | $148.97 M(+336.7%) |
| Sep 2012 | - | $34.12 M(-18.4%) |
| Jun 2012 | - | $41.83 M(-17.5%) |
| Mar 2012 | - | $50.71 M(-5.5%) |
| Dec 2011 | $1.74 M(>+9900.0%) | $53.66 M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Jun 2011 | - | $1700.00(+750.0%) |
| Mar 2011 | - | $200.00(-60.0%) |
| Dec 2010 | $0.00(0.0%) | $500.00(-76.2%) |
| Sep 2010 | - | $2100.00(+16.7%) |
| Jun 2010 | - | $1800.00(>+9900.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Dec 2009 | $0.00(0.0%) | $2400.00(+2300.0%) |
| Sep 2009 | - | $100.00(-95.8%) |
| Jun 2009 | - | $2400.00(+2300.0%) |
| Mar 2009 | - | $100.00(0.0%) |
| Dec 2008 | $0.00 | $100.00 |
FAQ
- What is Puma Biotechnology annual total current assets?
- What is the all time high annual current assets for Puma Biotechnology?
- What is Puma Biotechnology annual current assets year-on-year change?
- What is Puma Biotechnology quarterly total current assets?
- What is the all time high quarterly current assets for Puma Biotechnology?
- What is Puma Biotechnology quarterly current assets year-on-year change?
What is Puma Biotechnology annual total current assets?
The current annual current assets of PBYI is $156.19 M
What is the all time high annual current assets for Puma Biotechnology?
Puma Biotechnology all-time high annual total current assets is $236.47 M
What is Puma Biotechnology annual current assets year-on-year change?
Over the past year, PBYI annual total current assets has changed by +$21.90 M (+16.31%)
What is Puma Biotechnology quarterly total current assets?
The current quarterly current assets of PBYI is $156.82 M
What is the all time high quarterly current assets for Puma Biotechnology?
Puma Biotechnology all-time high quarterly total current assets is $316.69 M
What is Puma Biotechnology quarterly current assets year-on-year change?
Over the past year, PBYI quarterly total current assets has changed by +$31.46 M (+25.10%)